Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network
Grigoris Gerotziafas, Despina Fotiou, Inger S. Nijhof, Cihan Ay, Ramón Lecumberri, Alessandra Laroca, Gordon Cook, Monika Engelhardt, Sonja Zweegman, Michel Delforge, Anthony Maraveyas, Eleftheria Lefkou, Marina Marchetti, Niels W.C.J. van de Donk, Francesca Gay, H Ludwig, Hermann Einsele, Jesús F. San Miguel, Meletios A Dimopoulos, Mario Boccadoro, Pieter Sonneveld, Anna Falanga, Evangelos Terpos (2025). Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network. , 9(8), DOI: https://doi.org/10.1002/hem3.70177.
Article17 days agoEHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, Philippe Moreau, María‐Victoria Mateos, Sonja Zweegman, Gordon Cook, Monika Engelhardt, Michel Delforge, Roman Hájek, Fredrik Schjesvold, Francesca Gay, Morten Salomo, Katja Weisel, Martin Kaiser, Niels W.C.J. van de Donk, Elena Zamagni, Paula Rodríguez‐Otero, Aurore Perrot, Christoph Driessen, Jelena Bila, Edward Laane, Dominik Dytfeld, Cyrille Touzeau, Meral Beksac, Marc S. Raab, Michèle Cavo, Mohamad Mohty, Andrew Spencer, Heinz Ludwig, Hermann Einsele, Jesús F. San Miguel, Pieter Sonneveld (2025). EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma. , 22(9), DOI: https://doi.org/10.1038/s41571-025-01041-x.
Article17 days agoImpact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the <scp>BOSTON</scp> trial
María‐Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella, Michèle Cavo, Meletios A Dimopoulos, Martina Bianco, G Merlo, Charles la Porte, Paul G. Richardson, Philippe Moreau (2024). Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the <scp>BOSTON</scp> trial. , 113(2), DOI: https://doi.org/10.1111/ejh.14223.
Article17 days agoManagement of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W.C.J. van de Donk, Ioannis Ntanasis‐Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Philippe Moreau, Hermann Einsele, Jesús F. San Miguel, Mario Boccadoro, Meletios A Dimopoulos, Pieter Sonneveld, Heinz Ludwig (2023). Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). , 37(6), DOI: https://doi.org/10.1038/s41375-023-01920-1.
Article17 days agoP886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL
María‐Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella, Holger W. Auner, Michèle Cavo, Meletios A Dimopoulos, Martina Bianco, G Merlo, Charles la Porte, Philippe Moreau (2023). P886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL. , 7(S3), DOI: https://doi.org/10.1097/01.hs9.0000970448.14708.34.
Article17 days ago